Search Non-Antibody Products
|
|
|
|
|
Non-antibody Products (Kits, Proteins, Microbial Antigens, Tissues, Services, etc.) - Page 22 of 5,777
| Name |
Description |
Size |
Catalog # |
Supplier |
|
| AG013736 (Axitinib) |
Axitinib (also known as AG013736) is a small molecule tyrosine kinase inhibitor under development by Pfizer. It inhibits multiple targets, including VEGFR-1, VEGFR-2, VEGFR-3, platelet derived growth factor receptor (PDGFR), and cKIT (CD117). It h... |
25mg, 100mg |
A0927-01 |
UNITED STATES BIOLOGICAL |
More Info
|
| Axitinib (AG-013736) |
Axitinib (also known as AG-013736) is a small molecule tyrosine kinase inhibitor. It inhibits multiple targets, including VEGFR-1, VEGFR-2, VEGFR-3, PDGFR, and cKIT (CD117). It has been shown to significantly inhibit growth of breast cancer in xen... |
25 mg |
1581-25 |
BIOVISION, INC. |
More Info
|
| Axitinib (AG-013736) |
Axitinib (also known as AG-013736) is a small molecule tyrosine kinase inhibitor. It inhibits multiple targets, including VEGFR-1, VEGFR-2, VEGFR-3, PDGFR, and cKIT (CD117). It has been shown to significantly inhibit growth of breast cancer in xen... |
5 mg |
1581-5 |
BIOVISION, INC. |
More Info
|
| Axitinib |
VEGF Receptor Inhibitor |
10 mg |
4350/10 |
R&D SYSTEMS, INC. |
More Info
|
| Axl, active |
Purity: Purified using Ni2+/NTA agarose. Purity ~60%. N-terminal His6-tagged, recombinant amino acids 473-end human Axl expressed in Sf21 cells. Specific Activity: ~100U/mgUnit Definition: One unit of Axl activity is defined as 1nmol phosphate inc... |
5ug |
A4775 |
UNITED STATES BIOLOGICAL |
More Info
|
| Axltide |
Peptide sequence (KKSRGDYMTMQIG) is based on the mouse Insulin receptor substrate 1 (amino acid 979-989). |
1 mg |
A16-58 |
SIGNALCHEM |
More Info
|
| AY 9944 |
Calbiochem® brand product. |
5mg |
190080 |
EMD MILLIPORE |
More Info
|
| AZ 10417808 |
Minimum Purity: > 98%. Selective non-peptide inhibitor of caspase-3 (Ki = 247 nM); displays > 40-fold selectivity over caspases 1, 2, 6, 7 and 8 (Ki > 10 µM). Completely blocks staurosporine-induced intracellular DEVDase activity in SH-SY5Y ... |
10mg |
2172 |
TOCRIS BIOSCIENCE |
More Info
|
| AZ 10417808 |
Minimum Purity: > 98%. Selective non-peptide inhibitor of caspase-3 (Ki = 247 nM); displays > 40-fold selectivity over caspases 1, 2, 6, 7 and 8 (Ki > 10 µM). Completely blocks staurosporine-induced intracellular DEVDase activity in SH-SY5Y ... |
50mg |
2172 |
TOCRIS BIOSCIENCE |
More Info
|
| AZ 3146 |
Minimum Purity: > 99%. Potent and selective monopolar spindle 1 (Mps1) kinase inhibitor (IC50 = 35 nM). Displays selectivity over 46 other kinases including Cdk1 and aurora kinase B. Interferes with chromosome alignment and overrides spindle assem... |
50mg |
3994 |
TOCRIS BIOSCIENCE |
More Info
|
| AZ 3146 |
Minimum Purity: > 99%. Potent and selective monopolar spindle 1 (Mps1) kinase inhibitor (IC50 = 35 nM). Displays selectivity over 46 other kinases including Cdk1 and aurora kinase B. Interferes with chromosome alignment and overrides spindle assem... |
10mg |
3994 |
TOCRIS BIOSCIENCE |
More Info
|
| AZ 11645373 |
Minimum Purity: > 98%. Potent and selective human P2X7 antagonist (KB values are 5 - 7 and > 10,000 nM at hP2X7 and rP2X7 respectively) that is completely without effect at all other P2X subtypes. Inhibits BzATP-mediated calcium influx and inhibit... |
10mg |
3317 |
TOCRIS BIOSCIENCE |
More Info
|
| AZ 11645373 |
Minimum Purity: > 98%. Potent and selective human P2X7 antagonist (KB values are 5 - 7 and > 10,000 nM at hP2X7 and rP2X7 respectively) that is completely without effect at all other P2X subtypes. Inhibits BzATP-mediated calcium influx and inhibit... |
50mg |
3317 |
TOCRIS BIOSCIENCE |
More Info
|
| AZ 960 |
AZ 960 is a novel small molecule JAK2 kinase inhibitor with an IC50 and Ki of 3 mM and 0.45 nM in vitro, respectively. Purity is greater than 99%. |
10 mg |
orb60838 |
BIORBYT LTD. |
More Info
|
| AZ 10417808 |
Caspase Inhibitor |
10 mg |
2172/10 |
R&D SYSTEMS, INC. |
More Info
|
| AZ 10417808 |
Caspase Inhibitor |
50 mg |
2172/50 |
R&D SYSTEMS, INC. |
More Info
|
| AZ 11645373 |
P2X Receptor Antagonist |
10 mg |
3317/10 |
R&D SYSTEMS, INC. |
More Info
|
| AZ 11645373 |
P2X Receptor Antagonist |
50 mg |
3317/50 |
R&D SYSTEMS, INC. |
More Info
|
| AZ 3146 |
Other Kinase Inhibitor |
10 mg |
3994/10 |
R&D SYSTEMS, INC. |
More Info
|
| AZ 3146 |
Other Kinase Inhibitor |
50 mg |
3994/50 |
R&D SYSTEMS, INC. |
More Info
|
| Azacitidine |
Azacitidine(Vidaza)and its deoxy derivative, decitabine (5-aza-2?deoxycytidine), are used in the treatment of myelodysplastic syndrome. Purity is greater than 99%. |
10 mg |
orb60676 |
BIORBYT LTD. |
More Info
|
| 5-Azacytidine |
Minimum Purity: > 98%. DNA methyltransferase inhibitor. Incorporates into DNA forming covalent adducts with cellular DNMT1, depleting enzyme activity. Induces demethylation and reactivation of silenced genes. Improves the efficiency of reprogrammi... |
50mg |
3842 |
TOCRIS BIOSCIENCE |
More Info
|
| 5-Azacytidine |
A potent growth inhibitor and cytotoxic agent; a potent DNA methyltransferase inhibitor. Causes DNA demethylation or hemi-demethylation, creating openings that allow transcription factors to bind to DNA and reactivate tumor suppressor genes. Also ... |
50 mg |
1854-50 |
BIOVISION, INC. |
More Info
|
| 5-Azacytidine |
A potent growth inhibitor and cytotoxic agent; a potent DNA methyltransferase inhibitor. Causes DNA demethylation or hemi-demethylation, creating openings that allow transcription factors to bind to DNA and reactivate tumor suppressor genes. Also ... |
250 mg |
1854-250 |
BIOVISION, INC. |
More Info
|
| 5-Azacytidine |
Methyltransferase Inhibitor |
50 mg |
3842/50 |
R&D SYSTEMS, INC. |
More Info
|
| 7-Azagramine |
Melting Point: 152-157°CSolubility: Dichloromethane, Ethyl Acetate, MethanolStorage and Stability:May be stored at RT for short-term only. Long-term storage is recommended at -20°C. For maximum recovery of product, centrifuge the original ... |
2.5g |
A4934-20 |
UNITED STATES BIOLOGICAL |
More Info
|
| 1-Azakenpaullone |
Calbiochem® brand product. |
1mg |
191500 |
EMD MILLIPORE |
More Info
|
| 1-Azakenpaullone |
Purity: ~90%. A selective inhibitor of glycogen synthase kinase-3b.Melting Point:>250?C (dec.)Solubility:Methanol (Sparingly), DMSOMethod for Determining Identity:Proton NMR Spectroscopic and Mass Spectrometric AnalysisTLC Conditions:SiO2; Dichlor... |
5mg |
A4934-70 |
UNITED STATES BIOLOGICAL |
More Info
|
| 1-Azakenpaullone |
Cell-permeable. A Potent and ATP-competitive GSK-3beta (glycogen synthase kinase-3beta) inhibitor (IC50 = 18 nM). |
1 mg |
1944-1 |
BIOVISION, INC. |
More Info
|
| 1-Azakenpaullone |
Cell-permeable. A Potent and ATP-competitive GSK-3beta (glycogen synthase kinase-3beta) inhibitor (IC50 = 18 nM). |
5 mg |
1944-5 |
BIOVISION, INC. |
More Info
|
| Azathioprine |
World Health Organization (WHO) International Chemical Reference Substance |
100 mg |
ICRS0216 |
EUROPEAN DIRECTORATE FOR THE QUALITY OF MEDICINES & HEALTHCARE
|
More Info
|
| Azathioprine |
Minimum Purity: > 99%. Purine analog. Blocks DNA replication and the de novo pathway of purine synthesis. Immunosuppressive and anti-inflammatory drug; induces apoptosis in human T-lymphocytes. Prodrug of 6-mercaptopurine (Cat. No. 4103). |
50mg |
4099 |
TOCRIS BIOSCIENCE |
More Info
|
| Azathioprine |
Azathioprine(Azasan, Imuran) is a drug that suppresses the immune system and is used in organ transplantation and autoimmune disease. Purity is greater than 99%. |
10 mg |
orb60631 |
BIORBYT LTD. |
More Info
|
| Azathioprine |
n/a |
50 mg |
4099/50 |
R&D SYSTEMS, INC. |
More Info
|
| AZD 5438 |
Minimum Purity: > 99%. Potent inhibitor of cyclin-dependent kinase (cdk) 1, 2 and 9 (IC50 values are 16, 6 and 20 nM respectively). Exhibits antiproliferative activity in human tumor cell lines. Blocks cell cycling at G2-M, S and G1 phases; reduce... |
10mg |
3968 |
TOCRIS BIOSCIENCE |
More Info
|
| AZD 5438 |
Minimum Purity: > 99%. Potent inhibitor of cyclin-dependent kinase (cdk) 1, 2 and 9 (IC50 values are 16, 6 and 20 nM respectively). Exhibits antiproliferative activity in human tumor cell lines. Blocks cell cycling at G2-M, S and G1 phases; reduce... |
50mg |
3968 |
TOCRIS BIOSCIENCE |
More Info
|
| AZD0530 |
AZD0530 (Saracatinib) is a highly selective, orally available, dual-specific Src/Abl kinase inhibitor with IC50 of 2.7 and 30 nM for c-Src and Abl kinase, respectively. Purity is greater than 99%. |
5 mg |
orb60068 |
BIORBYT LTD. |
More Info
|
| AZD1480 |
AZD1480 is a novel potent small JAK2 inhibitor with an IC50 of 0.26 nM. Purity is greater than 99%. |
10 mg |
orb60804 |
BIORBYT LTD. |
More Info
|
| AZD2281 |
AZD2281 is a PARP inhibitor. IC50:PARP-1= 0.005 ?M, PARP-2= 0.001 ?M. Purity is greater than 99%. |
5 mg |
orb60110 |
BIORBYT LTD. |
More Info
|
| AZD6244 |
AZD6244 is MEK 1/2 inhibitor with GI50 values ranging from 14 to 50 nm. Purity is greater than 99%. |
5 mg |
orb60069 |
BIORBYT LTD. |
More Info
|
| AZD6482 |
AZD6482(PI3-kinase beta inhibitor) is a PI3Kbeta inhibitor (IC50=0.021?M) used in antithrombotic therapy. Purity is greater than 99%. |
10 mg |
orb60440 |
BIORBYT LTD. |
More Info
|
| AZD7762 |
AZD7762 is a novel checkpoint kinase inhibitor with an IC50 of 5 and <10 nM for CHK1 and CHK2, respectively. Purity is greater than 99%. |
5 mg |
orb60495 |
BIORBYT LTD. |
More Info
|
| AZD8055 |
AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mTOR kinase inhibitor with an IC50 of 0.8 nM. Purity is greater than 99%. |
5 mg |
orb60509 |
BIORBYT LTD. |
More Info
|
| AZD8330 |
AZD8330 is an orally active, selective MEK inhibitor with potential antineoplastic activity. Purity is greater than 99%. |
10 mg |
orb60781 |
BIORBYT LTD. |
More Info
|
| AZD8931 |
AZD8931 is a novel potent reversible small molecule epidermal growth factor receptor, ERBB2 (HER2) and ERBB3 inhibitor with an IC50 of 4, 3, 4 nM, respectively. Purity is greater than 99%. |
10 mg |
orb60821 |
BIORBYT LTD. |
More Info
|
| AZD 5438 |
Cyclin-dependent Protein Kinase Inhibitor |
10 mg |
3968/10 |
R&D SYSTEMS, INC. |
More Info
|
| AZD 5438 |
Cyclin-dependent Protein Kinase Inhibitor |
50 mg |
3968/50 |
R&D SYSTEMS, INC. |
More Info
|
| 2-Azidoadenosine |
Purity: ~90%. A useful synthetic intermediate for making potent and selective coronary vasodilators.Description: A useful synthetic intermediate for making potent and selective coronary vasodilators.Purity: ~90%Form: Supplied as an off-white to li... |
10mg |
A5007 |
UNITED STATES BIOLOGICAL |
More Info
|
| 8-Azidoadenosine |
Storage and Stability:May be stored at RT for short-term only. Long-term storage is recommended at -20°C. For maximum recovery of product, centrifuge the original vial and prior to removing the cap. |
50mg |
A5007-01 |
UNITED STATES BIOLOGICAL |
More Info
|
| 12-Azidododecylmethanethiosulfonate |
Reacts specifically and rapidly with thiols to form mixed disulfides. Solubility: Dichloromethane, Ether, Ethyl Acetate, MethanolStorage and Handling:Some methanethiosulfonates are hygroscopic and all hydrolyze in water, over a period of time, par... |
10mg |
A5017 |
UNITED STATES BIOLOGICAL |
More Info
|
Search Non-Antibody Products
|
Link To Us
Bookmark Us
Supplier Login
